Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole/Neomycin/Nystatin pessaries vs Tergynan for vaginitis
2024-518862-28-00Phase 3Suspended
- Sponsor
- Antibiotice Iași
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC) comparing Metronidazole/Neomycin sulfate/Nystatin pessaries with Tergynan vaginal tablets (2 arms). Primary endpoint: Clinical cure at V2 (BV and VVC). Started Nov 2024; status: suspended.
02
Drugs
metronidazole + neomycin sulfate + nystatinternidazole + neomycin + nystatin + prednisolone
03
Conditions
bacterial vaginosis (BV)vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on 2024-518862-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518862-28-00.